Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes
Tania Nikolcheva, … , Carol Clayberger, Alan M. Krensky
Tania Nikolcheva, … , Carol Clayberger, Alan M. Krensky
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):119-126. https://doi.org/10.1172/JCI15336.
View: Text | PDF
Article Immunology

A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes

  • Text
  • PDF
Abstract

Research Article

Authors

Tania Nikolcheva, Stephane Pyronnet, Szu-yi Chou, Nahum Sonenberg, An Song, Carol Clayberger, Alan M. Krensky

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
RFLAT-1 5′-UTR inhibits translation in vitro and in vivo. (a) Absorbance...
RFLAT-1 5′-UTR inhibits translation in vitro and in vivo. (a) Absorbance profile (254 nm) of sucrose gradients from lysates of resting (D0) or PHA-activated (D1 and D5) PBLs. (b) Nine fractions were collected from each gradient, and equal volumes of each fraction were separated on an agarose gel and analyzed by Northern hybridization with an RFLAT-1 probe. 18S and 28S rRNA in each fraction were visualized by ethidium bromide staining. (c) RFLAT-1 expression constructs. (full-length [RF] or lacking the 5′-UTR [ΔU]) were subjected to in vitro transcription-translation in the presence of 35S methionine. The products were detected by autoradiography. (d–g) pcDNA3.1 Luc (Luc) or pcDNA 3.1 5′-UTR Luc (5′-UTR Luc) were subjected to in vitro transcription-translation (d) or transiently transfected into Jurkat T cells (e and g) or HEK293 cells (f) and assayed for luciferase activity. The data are presented as relative luciferase activity where the activity of the 5′-UTR Luc construct is arbitrarily set to 1. *P < 0.05 (d, e, and f). Decreasing amounts of lysates from transfected Jurkat cells were subjected to an RPA (g) using luciferase (upper panel) and actin riboprobes (bottom panel). Lanes 2 and 5, 30 μl; 3 and 6, 15 μl; 4 and 7, 7.5 μl lysate.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts